Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?


OverviewForecastFinancialsChartTranscripts

Cognition Therapeutics Ownership Summary


Cognition Therapeutics is owned by 9.70% institutional investors, 0.59% insiders, and 89.70% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 9.70% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.63% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCognition Therapeutics9.70%0.59%89.70%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp6.00M9.70%$2.52M
Vanguard group1.24M3.07%$868.94K
Sigma planning614.49K1.52%$430.94K
Voss capital500.00K1.24%$350.65K
Geode capital management352.35K0.87%$247.14K
American financial group205.00K0.51%$143.77K
Cm management200.00K0.49%$140.26K
Blackrock152.58K0.45%$253.28K
Kestra advisory services177.43K0.44%$124.43K
Blackrock funding, inc. /de156.04K0.39%$109.43K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp6.00M3.19%$2.52M
Cm management200.00K0.13%$140.26K
American financial group205.00K0.07%$143.77K
Voss capital500.00K0.03%$350.65K
Sigma planning614.49K0.01%$430.94K
Castle wealth management43.38K0.01%$30.42K
Fca corp /tx51.47K0.01%$36.10K
Bangor savings bank34.02K0.00%$23.86K
Two sigma securities13.74K0.00%$9.64K
Gratus capital18.42K0.00%$30.58K

Top Buyers

HolderShares% AssetsChange
Voss capital500.00K0.03%500.00K
Sigma planning614.49K0.01%417.30K
Blackrock152.58K-96.76K
State street121.85K-59.10K
Two sigma investments, lp53.69K0.00%42.32K

Top Sellers

HolderShares% AssetsChange
Awm investment company---650.00K
Alyeska investment group---500.00K
Timelo investment management---361.40K
Aigh capital management---300.77K
Hohimer wealth management---225.00K

New Positions

HolderShares% AssetsChangeValue
Voss capital500.00K0.03%500.00K$350.65K
Envestnet asset management30.00K-30.00K$49.80K
Citadel advisors26.95K-26.95K$44.74K
Bryn mawr capital management23.34K0.00%23.34K$16.37K
Raymond james financial17.50K-17.50K$12.27K

Sold Out

HolderChange
Fmr-1.00
Opal wealth advisors-500.00
Sandy spring bank-2.00K
Qube research-2.12K
Jane street group-10.04K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-97.78%6,000,000-45.80%91.29%--100.00%--100.00%
Dec 31, 202430-23.08%10,129,593138.12%2522.62%13-18.75%650.00%
Sep 30, 202438-17.39%4,196,749-20.97%104.19%15-21.05%4-42.86%
Jun 30, 202446-5,310,353-25.11%153.56%19-24.00%7-12.50%
Mar 31, 20244627.78%7,090,800-0.89%213.70%2556.25%8300.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.01M1.63%-
Vanguard Institutional Extnd Mkt Idx Tr281.81K0.45%81.23K
Fidelity Extended Market Index197.68K0.32%12.22K
BlackRock Extended Equity Market K64.70K0.16%-27.00
iShares Micro-Cap ETF64.20K0.10%-
Extended Equity Market Fund K64.02K0.10%196.00
Fidelity Total Market Index59.10K0.10%-
Fidelity Series Total Market Index48.20K0.08%2.77K
Bridgeway Ultra-Small Company Market31.87K0.08%-44.83K
Spartan Extended Market Index Pool E27.11K0.04%1.62K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 31, 2025Ricciardi Lisa CEO & PresidentBuy$30.00K
Mar 14, 2024Ricciardi Lisa CEO & PresidentBuy$9.97K
Nov 29, 2022RICHSTONE ELLEN B-Buy$26.55K
Nov 28, 2022Fletcher Aaron G.L.-Buy$4.96K
Nov 28, 2022Fletcher Aaron G.L.-Buy$5.23K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q11-
2024 Q2--
2024 Q11-
2023 Q4--

CGTX Ownership FAQ


Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 9.70%, followed by 0.59% insiders and 89.71% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 63.96%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 9.70%), Vanguard group (1.24M shares, 3.07%), and Sigma planning (614.49K shares, 1.52%). Together, they hold 14.29% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

Yes, BlackRock owns 0.45% of Cognition Therapeutics, totaling 152.58K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 253.28K$. In the last quarter, BlackRock increased its holdings by 96.76K shares, a 173.34% change.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.19% of its assets in 6M Cognition Therapeutics shares, valued at 2.52M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 1.63% of its total shares outstanding invested in 1.01M Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools